Prodrugs of biologically active phosphate esters
- 24 January 2003
- journal article
- review article
- Published by Elsevier
- Vol. 11 (6) , 885-898
- https://doi.org/10.1016/s0968-0896(02)00552-7
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- γ-Aminobutyric Acid as Enzymolabile Groups for the Pro-oligonucleotide ApproachNucleosides and Nucleotides, 1999
- The pro-oligonucleotide approach. V: Influence of the phosphorus atom environment on the hydrolysis of enzymolabile dinucleoside phosphotriestersBioorganic & Medicinal Chemistry Letters, 1997
- Bioactivatable derivatives of 8-substituted cAMP-analoguesBioorganic & Medicinal Chemistry Letters, 1997
- Synthesis, Biological Activity and Decomposition Studies of Amino Acid Phosphomonoester Amidates of AcyclovirNucleosides and Nucleotides, 1997
- The Pronucleotide Approach. III. Synthesis, Anti-HBV Activity and Stability Studies of the Bis(S-pivaloyl-2-thioethyl) Phosphotriester Derivative of AcyclovirNucleosides and Nucleotides, 1997
- Cyclo-saligenyl-5-fluoro-2′-deoxyuridinemonophosphate (cycloSal-FdUMP) — A New Prodrug Approach for FdUMPNucleosides and Nucleotides, 1997
- Cyclo-Saligenyl-3′-Azido-2′,3′-Dideoxy- Thymidinemonophosphate (cycloSal-AZTMP) - A New Pro-Nucleotide Approach1 ?-Nucleosides and Nucleotides, 1997
- Prodrugs of phosphates, phosphonates, and phosphinatesAdvanced Drug Delivery Reviews, 1996
- Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiationNature, 1994
- Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolinesJournal of Medicinal Chemistry, 1988